Growth Metrics

Novavax (NVAX) Change in Acquisitions & Divestments (2016 - 2025)

Novavax has reported Change in Acquisitions & Divestments over the past 14 years, most recently at $98.6 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $98.6 million for Q4 2025, down 70.82% from a year ago — trailing twelve months through Dec 2025 was $353.7 million (down 20.25% YoY), and the annual figure for FY2025 was $353.7 million, down 20.25%.
  • Change in Acquisitions & Divestments for Q4 2025 was $98.6 million at Novavax, down from $100.5 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for NVAX hit a ceiling of $337.9 million in Q4 2024 and a floor of $2.2 million in Q2 2021.
  • Median Change in Acquisitions & Divestments over the past 3 years was $103.1 million (2024), compared with a mean of $119.6 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: tumbled 92.44% in 2021 and later decreased 4.84% in 2025.
  • Novavax's Change in Acquisitions & Divestments stood at $2.2 million in 2021, then skyrocketed by 14919.73% to $337.9 million in 2024, then tumbled by 70.82% to $98.6 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $98.6 million (Q4 2025), $100.5 million (Q3 2025), and $111.6 million (Q2 2025) per Business Quant data.